Abstract The cost and potential harms of medicines and other health technologies are issues of concern for governments and third party payers of health care. Various means have been demonstrated to promote appropriate evidence-based use of these technologies as a way to reduce waste and unintended variation. Since 1998, Australia has had a national organisation responsible for large scale programs to address safe, effective and cost effective use of health technologies. This article reviews 20 years of experience for NPS MedicineWise (NPS). NPS provides evidence-based information to health professionals and consumers using interventions that have been shown to be effective. A mix of academic detailing, audit and feedback and interactive lea...
Advances in medical technology have brought large benefits but have also been a major driver of incr...
ABSTRACTObjectiveTimely access to necessary medicines that Australians need is one of the four pilla...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
The National Prescribing Service (NPS) is an independent public company, working in partnership with...
Purpose: In Australia, nurse practitioner (NP) services are a relatively new development with little...
Health technology assessment (HTA) was introduced in Australia for the reimbursement of pharmaceutic...
Most pharmaceuticals in Australia are provided under the Pharmaceuticals Benefits Scheme (PBS) admin...
The Pharmaceutical Benefits Scheme (PBS) has served the Australian community well. Increased growth ...
Objective: A wealth of data is generated through Australia's universal health care arrangements. How...
© Pharmaceutical Society of AustraliaOBJECTIVES: Pharmacists are the 'gatekeepers' for Pharmacist On...
ObjectiveIdentifying and quantifying the health needs of a population are the basis of evidence-bas...
Pharmaceutical benefits provide a stable framework within which consumers, prescribers, suppliers, p...
Background: Providing written medicine information to consumers enables them to make informed decisi...
Advances in medical technology have brought large benefits but have also been a major driver of incr...
The author reflects on the state of play for nurse practitioners (NPs) in Australia in 2008. Accordi...
Advances in medical technology have brought large benefits but have also been a major driver of incr...
ABSTRACTObjectiveTimely access to necessary medicines that Australians need is one of the four pilla...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
The National Prescribing Service (NPS) is an independent public company, working in partnership with...
Purpose: In Australia, nurse practitioner (NP) services are a relatively new development with little...
Health technology assessment (HTA) was introduced in Australia for the reimbursement of pharmaceutic...
Most pharmaceuticals in Australia are provided under the Pharmaceuticals Benefits Scheme (PBS) admin...
The Pharmaceutical Benefits Scheme (PBS) has served the Australian community well. Increased growth ...
Objective: A wealth of data is generated through Australia's universal health care arrangements. How...
© Pharmaceutical Society of AustraliaOBJECTIVES: Pharmacists are the 'gatekeepers' for Pharmacist On...
ObjectiveIdentifying and quantifying the health needs of a population are the basis of evidence-bas...
Pharmaceutical benefits provide a stable framework within which consumers, prescribers, suppliers, p...
Background: Providing written medicine information to consumers enables them to make informed decisi...
Advances in medical technology have brought large benefits but have also been a major driver of incr...
The author reflects on the state of play for nurse practitioners (NPs) in Australia in 2008. Accordi...
Advances in medical technology have brought large benefits but have also been a major driver of incr...
ABSTRACTObjectiveTimely access to necessary medicines that Australians need is one of the four pilla...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...